Why the study?
Myocardial inflammation contributes to cardiomyopathy in diabetic patients through incompletely defined underlying mechanisms.
Does sequestering extracellular HMGB1 with glycyrrhizin attenuate myocardial inflammation and cardiac dysfunction in models of diabetic cardiomyopathy?
Does sequestering extracellular HMGB1 with glycyrrhizin attenuate myocardial inflammation and cardiac dysfunction in models of diabetic cardiomyopathy?
This study identifies an ER stress-mediated cardiomyocyte-macrophage link via HMGB1 in diabetic cardiomyopathy and suggests sequestering HMGB1 as a potential therapeutic strategy.
Sequestering HMGB1 attenuates inflammation in diabetic cardiomyopathy models; hypothesis-generating and leaves open clinical translation.
Myocardial inflammation contributes to cardiomyopathy in diabetic patients through incompletely defined underlying mechanisms. In both human and time-course experimental samples, diabetic hearts exhibited abnormal ER, with a maladaptive shift over time in rodents. Furthermore, as a cardiac ER dysfunction model, mice with cardiac-specific p21-activated kinase 2 (PAK2) deletion exhibited heightened myocardial inflammatory response in diabetes. Mechanistically, maladaptive ER stress-induced CCAAT/enhancer-binding protein homologous protein (CHOP) is a novel transcriptional regulator of cardiac high-mobility group box-1 (HMGB1). Cardiac stress-induced release of HMGB1 facilitates M1 macrophage polarization, aggravating myocardial inflammation. Therapeutically, sequestering the extracellular HMGB1 using glycyrrhizin conferred cardioprotection through its anti-inflammatory action. Our findings also indicated that an intact cardiac ER function and protective effects of the antidiabetic drug interdependently attenuated the cardiac inflammation-induced dysfunction. Collectively, we introduce an ER stress-mediated cardiomyocyte-macrophage link, altering the macrophage response, thereby providing insight into therapeutic prospects for diabetes-associated cardiac dysfunction.
No takes yet. Share an insight, caveat, or question.
Kaur et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: